BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sommerkamp P, Cabezas-Wallscheid N, Trumpp A. Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation. Trends Mol Med 2021;27:660-72. [PMID: 33985920 DOI: 10.1016/j.molmed.2021.04.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Li QQ. Coupling epigenetics and RNA polyadenylation: missing links. Trends Plant Sci 2023;28:223-34. [PMID: 36175275 DOI: 10.1016/j.tplants.2022.08.023] [Reference Citation Analysis]
2 Ji Y, Ge Q, Zhang W, Qu P. Molecular Features, Prognostic Value, and Cancer Immune Interactions of Angiogenesis-Related Genes in Ovarian Cancer. Reprod Sci 2022. [DOI: 10.1007/s43032-022-01123-6] [Reference Citation Analysis]
3 Berry CW, Olivares GH, Gallicchio L, Ramaswami G, Glavic A, Olguín P, Li JB, Fuller MT. Developmentally regulated alternate 3' end cleavage of nascent transcripts controls dynamic changes in protein expression in an adult stem cell lineage. Genes Dev 2022;36:916-35. [PMID: 36175033 DOI: 10.1101/gad.349689.122] [Reference Citation Analysis]
4 Berry CW, Olivares GH, Gallicchio L, Ramaswami G, Glavic A, Olguín P, Li JB, Fuller MT. Developmentally regulated alternate 3’ end cleavage of nascent transcripts controls dynamic changes in protein expression in an adult stem cell lineage.. [DOI: 10.1101/2022.05.09.489277] [Reference Citation Analysis]
5 Sommerkamp P, Sommerkamp AC, Zeisberger P, Eiben PL, Narr A, Korkmaz A, Przybylla A, Sohn M, van der Hoeven F, Schönig K, Trumpp A. CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells. Sci Rep 2022;12:7181. [PMID: 35504940 DOI: 10.1038/s41598-022-11203-x] [Reference Citation Analysis]
6 Joachimiak P, Ciesiołka A, Figura G, Fiszer A. Implications of Poly(A) Tail Processing in Repeat Expansion Diseases. Cells 2022;11:677. [DOI: 10.3390/cells11040677] [Reference Citation Analysis]
7 Sommerkamp P, Trumpp A. Driving differentiation: targeting APA in AML. Blood 2022;139:317-9. [PMID: 35050335 DOI: 10.1182/blood.2021013814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yang Y, Wu X, Yang W, Jin W, Wang D, Yang J, Jiang G, Zhang W, Niu X, Gong J. Dynamic alternative polyadenylation during iPSC differentiation into cardiomyocytes. Computational and Structural Biotechnology Journal 2022;20:5859-5869. [DOI: 10.1016/j.csbj.2022.10.025] [Reference Citation Analysis]
9 Navarro E, Mallén A, Hueso M. Dynamic Variations of 3'UTR Length Reprogram the mRNA Regulatory Landscape. Biomedicines 2021;9:1560. [PMID: 34829789 DOI: 10.3390/biomedicines9111560] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Kim SH, Choi KY, Park Y, McLean C, Park J, Lee JH, Lee KH, Kim BC, Huh YH, Lee KH, Song WK. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes. Cells 2021;10:2697. [PMID: 34685681 DOI: 10.3390/cells10102697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Gillen SL, Waldron JA, Bushell M. Codon optimality in cancer. Oncogene 2021;40:6309-20. [PMID: 34584217 DOI: 10.1038/s41388-021-02022-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Dharmalingam P, Mahalingam R, Yalamanchili HK, Weng T, Karmouty-Quintana H, Guha A, A Thandavarayan R. Emerging roles of alternative cleavage and polyadenylation (APA) in human disease. J Cell Physiol 2021. [PMID: 34378793 DOI: 10.1002/jcp.30549] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Sun X, Liu Q, Huang J, Diao G, Liang Z. Transcriptome-based stemness indices analysis reveals platinum-based chemo-theraputic response indicators in advanced-stage serous ovarian cancer. Bioengineered 2021;12:3753-71. [PMID: 34266348 DOI: 10.1080/21655979.2021.1939514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]